Barriers to overcoming immunotherapy resistance in glioblastoma
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1175507
Abstract: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, known for its poor prognosis and high recurrence rate. Current standard of care includes surgical resection followed by combined radiotherapy and chemotherapy. Although immunotherapies… read more here.
Keywords: glioblastoma; resistance; gbm; overcoming immunotherapy ... See more keywords